Imdatifan (HIF-2α-IN-7) is a hypoxia-inducible factor 2α (HIF-2α) inhibitor with an EC50 value of 6 nM; it can be used in the research of various diseases, including cancer, liver diseases, inflammatory diseases, lung diseases, and iron overload disorders.